DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Marty M, Cognetti F, Maraninchi D et al.
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
J Clin Oncol 2005;
23: 4265-4274
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.